胆管癌市场规模、份额及成长分析（按适应症、治疗、最终用户、地区和细分市场预测），2025 年至 2032 年

2023 年全球胆管癌市场规模价值为 36 亿美元，预计将从 2024 年的 39.1 亿美元成长到 2032 年的 75 亿美元，预测期间（2025-2032 年）的复合年增长率为 8.5%。

由于发病率上升、技术进步和研发增加，胆管癌市场正在经历显着增长。美国每年约有 8,000 人被诊断出患有胆管癌，发病率呈上升趋势，尤其是在老年人口和受肝流感和肝炎影响的地区。 PET-CT 和 MRI 等影像技术的创新正在增强早期检测和治疗计划，纪念斯隆凯特琳癌症中心等机构使用先进技术就是一个例证。此外，艾伦·莫雷门特纪念基金等日益增强的宣传活动强调了研究病因和治疗方法的重要性。然而，挑战依然存在，包括晚期治疗选择有限、治疗费用高以及早期诊断困难，尤其是在低收入国家。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 定价分析
• 案例研究分析
• 技术分析
• 临床试验分析
• FDA核准的药物分析
• 监管分析

胆管癌市场规模（依适应症）

• 市场概览
• 肝外胆管癌
  • 肝门部胆管癌
  • 远端胆管癌
• 肝内胆管癌

胆管癌治疗市场规模

• 市场概览
• 外科手术
  • 腹腔镜检查
  • 胆道旁路
  • 支架置入
  • 其他的
• 放射治疗
  • 体外放射线治疗（EBRT）
  • 体内放射疗法
• 化疗
• 标靶药物治疗
  • FGFR2抑制剂
  • IDH1抑制剂
  • TRK抑制剂
  • 其他的
• 免疫疗法
• 安宁疗护

胆管癌市场规模（依最终用户）

• 市场概览
• 医院和诊所
• 癌症诊所
• 其他的

胆管癌市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Memorial Sloan Kettering Cancer Center（MSK）
• The University of Texas MD Anderson Cancer Center
• City of Hope
• Mass General Brigham Incorporated
• Scripps Health
• Moffitt
• Cleveland Clinic
• Winship Cancer Institute of Emory University
• penn Medicine（Abramson Cancer Center）
• University Hospitals
• Kokilaben Dhirubhai Ambani Hospital
• Apollo Hospitals
• BLK-Max Super Speciality Hospital
• Max Healthcare
• Mayo Clinic
• Dana-Farber Cancer Institute
• Johns Hopkins Hospital
• Mount Sinai Hospital
• UCSF Health-UCSF Medical Center
• UCLA Medical Center

结论和建议

Global Bile Duct Cancer Market size was valued at USD 3.6 billion in 2023 and is poised to grow from USD 3.91 billion in 2024 to USD 7.5 billion by 2032, growing at a CAGR of 8.5% during the forecast period (2025-2032).

The bile duct cancer market is experiencing substantial growth driven by rising incidence rates, technological advancements, and increased research and development. Each year, approximately 8,000 individuals in the U.S. are diagnosed with cholangiocarcinoma, with prevalence rising, particularly among aging populations and regions affected by liver fluke infections and hepatitis. Innovations in diagnostic imaging, including PET-CT and MRI, enhance early detection and treatment planning, exemplified by the use of advanced techniques at institutions like Memorial Sloan Kettering Cancer Center. Additionally, growing awareness initiatives, such as those by the Alan Morement Memorial Fund, highlight the importance of research into causes and treatments. However, challenges remain, including limited late-stage therapies, high treatment costs, and difficulties in early diagnosis, particularly in lower-income countries.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bile Duct Cancer market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bile Duct Cancer Market Segments Analysis

Global Bile Duct Cancer Market is segmented by Indication, By Treatment, By End User and region. Based on By Indication, the market is segmented into Extrahepatic Bile Duct Cancer and Intrahepatic Bile Duct Cancer. Based on By Treatment, the market is segmented into Surgery, Radiation Therapy, Chemotherapy, Targeted Drug Therapy, Immunotherapy and Palliative Therapy. Based on By End User, the market is segmented into Hospital & Clinics, Cancer Specialty Clinic and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bile Duct Cancer Market

The global bile duct cancer market is experiencing robust growth driven by the increasing incidence of bile duct cancer and the expanding elderly population. Older adults are particularly susceptible to cancer due to a compromised immune system and extended exposure to risk factors, including chronic liver disease and liver infections. As a result, the projected statistics indicate a significant rise in cancer cases and fatalities among senior demographics, with anticipated figures of approximately 20.7 million new cases and 12.7 million deaths by 2040. This escalating prevalence underscores the urgent need for advancements in treatment and care strategies within the market.

Restraints in the Global Bile Duct Cancer Market

The Global Bile Duct Cancer market faces significant restraints due to the severe side effects associated with various cancer treatments, hindering patient adherence and overall market growth. Standard treatment options, including chemotherapy, targeted drug therapy, and radiation therapy, commonly lead to adverse effects that drastically impact patients' quality of life. These side effects often include hair loss, fatigue, nausea, and neutropenia. Additionally, the apprehension regarding treatment-related toxicity affects patients' decisions regarding their treatment options and their readiness to participate in clinical trials, ultimately impeding the advancement of new therapeutic innovations in the market.

Market Trends of the Global Bile Duct Cancer Market

In the short term, the Global Bile Duct Cancer market is poised for significant growth, propelled by heightened awareness around early diagnosis and the demand for personalized treatment solutions. Innovations in diagnostic technologies, including molecular profiling and AI-assisted imaging, are set to improve treatment accuracy and efficiency. Moreover, the rising emphasis on precision medicine, coupled with the development of targeted therapies, is enhancing treatment options, enabling healthcare providers to offer bespoke therapeutic strategies that cater to individual patient profiles. As a result, these trends are collectively driving market expansion and fostering a positive outlook for the bile duct cancer sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Pricing Analysis
• Case Study Analysis
• Technology Analysis
• Clinical Trial Analysis
• Fda Approval Drug Analysis
• Regulatory Analysis

Global Bile Duct Cancer Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Extrahepatic Bile Duct Cancer
  • Hilar Bile Duct Cancer
  • Distal Bile Duct Cancer
• Intrahepatic Bile Duct Cancer

Global Bile Duct Cancer Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Surgery
  • Laparoscopy
  • Biliary bypass
  • Stent placement
  • Others
• Radiation Therapy
  • External beam radiation therapy (EBRT)
  • Internal radiation therapy
• Chemotherapy
• Targeted Drug Therapy
  • FGFR2 Inhibitors
  • IDH1 Inhibitor
  • TRK Inhibitors
  • Others
• Immunotherapy
• Palliative Therapy

Global Bile Duct Cancer Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospital & Clinics
• Cancer Specialty Clinic
• Others

Global Bile Duct Cancer Market Size & CAGR (2025-2032)

• North America (By Indication, By Treatment, By End User)
  • US
  • Canada
• Europe (By Indication, By Treatment, By End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (By Indication, By Treatment, By End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (By Indication, By Treatment, By End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (By Indication, By Treatment, By End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Memorial Sloan Kettering Cancer Center (MSK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The University of Texas MD Anderson Cancer Center
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• City of Hope
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mass General Brigham Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Scripps Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Moffitt
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cleveland Clinic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Winship Cancer Institute of Emory University
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• penn Medicine (Abramson Cancer Center)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• University Hospitals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kokilaben Dhirubhai Ambani Hospital
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apollo Hospitals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BLK-Max Super Speciality Hospital
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Max Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mayo Clinic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dana-Farber Cancer Institute
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johns Hopkins Hospital
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mount Sinai Hospital
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UCSF Health-UCSF Medical Center
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UCLA Medical Center
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations